171 related articles for article (PubMed ID: 38613660)
1. A Blueprint for Multi-use Disease Modeling in Health Economics: Results from Two Expert-Panel Consultations.
Wang J; Pouwels X; Ramaekers B; Frederix G; van Lieshout C; Hoogenveen R; Li X; de Wit GA; Joore M; Koffijberg H; van Giessen A; Knies S; Feenstra T;
Pharmacoeconomics; 2024 Jul; 42(7):797-810. PubMed ID: 38613660
[TBL] [Abstract][Full Text] [Related]
2. Prioritising models of healthcare service delivery for a more sustainable health system: a Delphi study of Australian health policy, clinical practice and management, academic and consumer stakeholders.
Putrik P; Jessup R; Buchbinder R; Glasziou P; Karnon J; O Connor DA
Aust Health Rev; 2021 Aug; 45(4):425-432. PubMed ID: 33731250
[TBL] [Abstract][Full Text] [Related]
3. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
[TBL] [Abstract][Full Text] [Related]
4. 360-degree Delphi: addressing sociotechnical challenges of healthcare IT.
Waldmüller H; Spreckelsen C; Rudat H; Krumm N; Rolke R; Jonas SM
BMC Med Inform Decis Mak; 2020 Jun; 20(1):101. PubMed ID: 32503609
[TBL] [Abstract][Full Text] [Related]
5. Preapproval Information Exchange: Perspectives of U.S. Population Health Decision Makers on Preferences for Early Engagement with Investigational Therapies.
Brixner D; Woodward TC; Seifter N; Biskupiak J; Marciniak M; Neumann P; Oderda G
J Manag Care Spec Pharm; 2019 Feb; 25(2):164-173. PubMed ID: 30698089
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods study.
Bojke L; Soares M; Claxton K; Colson A; Fox A; Jackson C; Jankovic D; Morton A; Sharples L; Taylor A
Health Technol Assess; 2021 Jun; 25(37):1-124. PubMed ID: 34105510
[TBL] [Abstract][Full Text] [Related]
8. A model for HTA priority setting: experience in Lithuania.
Jankauskiene D; Petronyte G
Int J Technol Assess Health Care; 2013 Oct; 29(4):450-5. PubMed ID: 24290339
[TBL] [Abstract][Full Text] [Related]
9. Four Aspects Affecting Health Economic Decision Models and Their Validation.
Feenstra T; Corro-Ramos I; Hamerlijnck D; van Voorn G; Ghabri S
Pharmacoeconomics; 2022 Mar; 40(3):241-248. PubMed ID: 34913142
[TBL] [Abstract][Full Text] [Related]
10. Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus Survey.
Thorn JC; Davies CF; Brookes ST; Noble SM; Dritsaki M; Gray E; Hughes DA; Mihaylova B; Petrou S; Ridyard C; Sach T; Wilson ECF; Wordsworth S; Hollingworth W
Value Health; 2021 Apr; 24(4):539-547. PubMed ID: 33840432
[TBL] [Abstract][Full Text] [Related]
11. Multi-disciplinary supportive end of life care in long-term care: an integrative approach to improving end of life.
Harasym PM; Afzaal M; Brisbin S; Sinnarajah A; Venturato L; Quail P; Kaasalainen S; Straus S; Sussman T; Virk N; Holroyd-Leduc JM
BMC Geriatr; 2021 May; 21(1):326. PubMed ID: 34022818
[TBL] [Abstract][Full Text] [Related]
12. Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey.
Vokó Z; Cheung KL; Józwiak-Hagymásy J; Wolfenstetter S; Jones T; Muñoz C; Evers SM; Hiligsmann M; de Vries H; Pokhrel S;
Health Res Policy Syst; 2016 May; 14(1):38. PubMed ID: 27230485
[TBL] [Abstract][Full Text] [Related]
13. Policy relevant results from an expert elicitation on the health risks of phthalates.
Zimmer KE; Gutleb AC; Ravnum S; Krayer von Krauss M; Murk AJ; Ropstad E; Skaare JU; Eriksen GS; Lyche JL; Koppe JG; Magnanti BL; Yang A; Bartonova A; Keune H
Environ Health; 2012 Jun; 11 Suppl 1(Suppl 1):S6. PubMed ID: 22759506
[TBL] [Abstract][Full Text] [Related]
14. Developing a decision support system to link health technology assessment (HTA) reports to the health system policies in Iran.
Yazdani S; Jadidfard MP
Health Policy Plan; 2017 May; 32(4):504-515. PubMed ID: 28025325
[TBL] [Abstract][Full Text] [Related]
15. Health technology assessment and priority setting for universal health coverage: a qualitative study of stakeholders' capacity, needs, policy areas of demand and perspectives in Nigeria.
Uzochukwu BSC; Okeke C; O'Brien N; Ruiz F; Sombie I; Hollingworth S
Global Health; 2020 Jul; 16(1):58. PubMed ID: 32641066
[TBL] [Abstract][Full Text] [Related]
16. One step at a time. Shaping consensus on research priorities and terminology in telehealth in musculoskeletal pain: an international modified e-Delphi study.
Fandim JV; Hinman RS; Øverås CK; Sharma S; Belton J; Oliveira VC; Dear BF; Parker R; Ghai B; Bennell KL; Ferreira P; Hartvigsen J; Saragiotto BT
BMC Musculoskelet Disord; 2023 Oct; 24(1):783. PubMed ID: 37789304
[TBL] [Abstract][Full Text] [Related]
17. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
[TBL] [Abstract][Full Text] [Related]
18. Establishing a critical pathway for Korean medical management of lumbar disc herniation: A modified Delphi consensus process.
Kim JH; Goo B; Seo BK
Medicine (Baltimore); 2021 Aug; 100(33):e26991. PubMed ID: 34414980
[TBL] [Abstract][Full Text] [Related]
19. Understanding the evolution of coverage policies for prophylaxis treatments of hemophilia A without inhibitors: a payer Delphi panel.
Graf M; Tuly R; Harley C; Pednekar P; Batt K
J Manag Care Spec Pharm; 2021 Aug; 27(8):996-1008. PubMed ID: 33843253
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
